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Structure of the Ribosomal RNA Decoding Site Containing
a Selenium-Modified Responsive Fluorescent Ribonucleoside Probe
Ashok Nuthanakanti+, Mark A. Boerneke+, Thomas Hermann,* and Seergazhi G. Srivatsan*
Abstract: Comprehensive understanding of the structure–
function relationship of RNA both in real time and at atomic
level will have a profound impact in advancing our under-
standing of RNA functions in biology. Here, we describe the
first example of a multifunctional nucleoside probe, containing
a conformation-sensitive fluorophore and an anomalous X-ray
diffraction label (5-selenophene uracil), which enables the
correlation of RNA conformation and recognition under
equilibrium and in 3D. The probe incorporated into the
bacterial ribosomal RNA decoding site, fluorescently reports
antibiotic binding and provides diffraction information in
determining the structure without distorting native RNA fold.
Further, by comparing solution binding data and crystal
structure, we gained insight on how the probe senses ligand-
induced conformational change in RNA. Taken together, our
nucleoside probe represents a new class of biophysical tool that
would complement available tools for functional RNA inves-
tigations.
Biophysical techniques including fluorescence labeling,
NMR, EPR and X-ray crystallography have provided val-
uable information on RNA folding, molecular recognition
and function.[1–4] Such investigations mostly involve RNA
sequences labeled with appropriate reporters as natural
nucleosides are practically non-fluorescent and do not
provide intrinsic labels that are suitable for analysis by
spectroscopic and diffraction techniques.[5] Minimally per-
turbing fluorescent nucleoside analogs,[6] isotope- (e.g., 13C,
15N),[7] spin- (e.g., nitroxide)[8] and heavy-atom-labeled (e.g.,
Br, Se)[9] nucleosides incorporated into oligonucleotides
(ONs) have been applied in assays to study structure,
dynamics and function of RNA. However, given the multi-
tude and diversity of RNA transcripts, probing structure–
function relationships of RNA sequences using established
biochemical and biophysical methods remains a major chal-
lenge.[10] This is largely due to the lack of chemical probes that
can be efficiently deployed in multiple biophysical techniques
as almost all studies use the traditional approach of “one
label-one technique”, wherein a custom labeled RNA suit-
able for a particular technique is used. Therefore, develop-
ment of smart chemical tools that can 1) be readily incorpo-
rated into RNA ONs and 2) enable the direct correlation of
RNA structure and function in real time and in 3D is highly
desired. We concluded that ribonucleoside probes containing
multiple labels (e.g., a fluorophore and an anomalous X-ray
scattering label) would be advantageous as they would serve
as common probes to analyze RNA conformation and
function in solution in real time by fluorescence and,
concurrently, RNA structure in the solid-state by X-ray
crystallography (Figure 1 and Figure S1).
Here, we describe the first example of a dual-purpose
ribonucleoside probe (SeU), based on the 5-(selenophen-2-
yl)uracil scaffold, which provides a tool for comprehensive
investigations of RNA–drug interaction by fluorescence and
X-ray crystallography techniques (Figure 1). The nucleoside
probe was chemically incorporated into the bacterial riboso-
mal decoding site (A-site), and the environmental sensitivity
of the fluorophore was used for monitoring the binding of
aminoglycoside antibiotics. X-ray diffraction analysis of A-
site RNA crystals containing the modified uridine revealed
a prominent diffraction signal from the selenium atom and
also provided insight into the structural basis on how the
Figure 1. Chemical structure of 5-selenophene-modified nucleoside
probe (1 or SeU) and corresponding phosphoramidite 2.[11] Incorpora-
tion of SeU into the RNA target (e.g., A-site) would enable simulta-
neous biophysical investigation of the same RNA construct in solution
by fluorescence techniques and in the solid-state by X-ray crystallog-
raphy.
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nucleoside probe senses conformational changes in RNA
during ligand binding.
We recently introduced a 5-selenophene-modified uridine
analog (1), which is composed of an environment-sensitive
base-modified fluorescent nucleobase and an X-ray crystal-
lography phasing agent (Se atom, Figure 1).[12] Selenium
provides key advantages over halogen modification. First, Se
gives rise to a strong anomalous scattering signal, which has
been widely used in protein crystallography and more
recently in nucleic acid analysis.[13] Second, halogen-modified
ONs are known to undergo dehalogenation when exposed to
X-ray radiation causing failures in phasing.[14] Ribonucleoside
1 has an emission maximum in the visible region (lem=
452 nm in water), and exhibits probe-like properties (e.g.,
solvatochromism and viscochromism). The corresponding
ribonucleotide can be effectively incorporated into ONs by
enzymatic in vitro transcription[12] and used to monitor RNA-
ligand binding by fluorescence. Based on these observations
we sought to explore the fluorescent and anomalous X-ray
scattering properties of the uridine analog 1 as a common
RNA probe in complementing solution and solid-state
techniques, namely fluorescence and X-ray crystallography.
We chose bacterial A-site RNA as the test system, which is
a well-studied target for aminoglycoside antibiotics.[15] In this
system, the effect of selenophene modification on the RNA
structure and its ability to faithfully report drug binding to A-
site in solution and solid state can be validated by direct
comparison with previously reported data on A-site amino-
glycoside complexes.[16]
The A-site motif in 16S rRNA serves as the decoding site
for protein translation by screening cognate paring between
the mRNA codon and tRNA anticodon.[17] Biochemical and
structural studies revealed that natural aminoglycoside anti-
biotics bind to the RNA decoding site at an internal loop
which contains two conformationally flexible adenosine
residues (A1492 and A1493, Figure 2).[18] A-site-aminoglyco-
side complexes are further stabilized by direct and water-
bridged H-bonding interactions with the U1406-U1495 non-
canonical base pair. Aminoglycoside binding induces a con-
formational change analogous to cognate tRNA bound to
mRNA in the A-site wherein A1492 and A1493 are pushed
out of the internal loop. This conformational change reduces
the ability of the decoding site to discriminate between
cognate and near-cognate tRNAs and ultimately leads to
mistranslation. Short duplexes and stem-loop RNA ONs
faithfully representing the wild-type decoding site of rRNA
have been used as models to investigate the structure and
recognition properties of the A-site.[18a,b] A-site RNA models
containing fluorescent nucleoside analogs (e.g., 2-aminopur-
ine; 2-AP) at positions A1492/A1493/U1406 have been used
in assays to monitor aminoglycoside binding.[19] Based on
these studies, we devised a labeled A-site model suitable for
both fluorescence and X-ray studies by replacing U1406 with
the nucleoside SeU.
We have used bipartite ONs 3 and 4 comprising the
bacterial decoding site sequence to assemble the A-site RNA
motif 3·4 (Figure 2). Preparation of the phosphoramidite
building block 2 required for the synthesis of SeU-modified
RNA ON 3 is outlined in Scheme S1 in the Supporting
Information.[11] The phosphoramidite 2 was site-specifically
incorporated by solid-phase ON synthesis. Fully deprotected
ON 3 was purified by polyacrylamide gel electrophoresis
(PAGE, Figure S2). The integrity of SeU-modified ON 3 was
confirmed by MALDI-TOF mass analysis (Figure S2). The
labeled A-site construct (3·4) was assembled by hybridizing
equimolar amounts of ON 3 and 4 in cacodylate buffer. The
impact of the selenophene modification on the A-site
structure and stability was studied by circular dichroism
(CD) and thermal melting experiments. Both, control
unmodified 5·4 and modified A-site 3·4 RNAs displayed
similar CD spectra and Tm values indicating that the
selenophene modification had only a minor effect on the
native structure and stability of the A-site RNA (Figure S3).
The ability of the nucleoside probe to photophysically
report a ligand-induced conformational change in the A-site
was evaluated by titrating RNA 3·4 with aminoglycoside
antibiotics derived from 2-deoxystreptamine (2-DOS). We
chose 4,5-disubstituted 2-DOS (paromomycin and neomy-
cin B) and 4,6-disubstituted 2-DOS (tobramycin) aminogly-
cosides as they are known to reduce translation fidelity in
bacteria by interacting with residues present in the internal
loop of the decoding site (Figure 2).[17, 18] A-site model RNA
was excited at 330 nm, and changes in emission intensity at
lem= 450 nm were monitored as a function of increasing
concentration of aminoglycosides. Titration with paromomy-
cin and neomycin resulted in an increase in fluorescence
intensity, corresponding to an apparent KD of 3.80: 0.20 mm
and 2.10: 0.22 mm, respectively (Figure 3 and Figure S4). The
binding constant and higher affinity exhibited by neomycin
compared to paromomycin are consistent with literature
reports (KD& 10@6m).[19a–c] It is important to note that 2-AP,
the most widely used conformation-sensitive nucleoside
probe, fails to report the binding of neomycin to A-site
RNA despite that both paromomycin and neomycin are
known to bind the RNA target in a similar fashion and result
in ribosomal miscoding during translation.[16, 19] Next, we
studied the binding of tobramycin, which binds A-site RNA
with lower affinity compared to 4,5-disubstituted 2-DOS
aminoglycosides.[18b] SeU reported the binding of tobramycin
Figure 2. Secondary structure of selenophene-modified (3·4) and
native (5·4) bacterial A-site model RNA.[11] The decoding site internal
loop that binds aminoglycosides is highlighted in bold letters. On the
right, aminoglycosides used in this study are shown.
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with discernible enhancement in fluorescence intensity, albeit
with reduced affinity compared to the native decoding site
(66.3: 5.9 mm and 9.5: 2.0 mm, respectively, Figure S5).[19a]
In order to elucidate the structural basis of conformation
sensitivity of the nucleoside analog and allow a direct
comparison between solution binding data and crystallo-
graphic structure, selenophene-modified A-site model RNA
3·4 was crystallized and its 3D structure determined by X-ray
diffraction at 2.14c resolution (PDB: 5T3K). Hanging-drop
vapor diffusion resulted in well-diffracting crystals, which
contained two unique A-site RNA molecules with 50%
occupancy in the unit cell (Figure S6, Table S1). In one of the
RNA copies, both A1492 and A1493 residues were flipped-
out of the loop, closely resembling the structure of the
decoding site bound to aminoglycosides (Figure 4, top). In the
second RNA copy, only A1493 was flipped-out of the loop,
while A1492 was found to be inside, base pairing and stacking
with A1408 and G1491, respectively (Figure 4, bottom and
Table S2). Other than these differences the two A-site copies
were nearly identical. Importantly, the electron density of the
heavy Se atom was clearly visible, establishing the orientation
of the 5-membered ring as coplanar with the pyrimidine and
Se facing the carbonyl O4. Like U1406 in the native decoding
site, SeU1406 also formed a noncanonical Watson–Crick pair
with U1495 (Figure S7, Table S2). The characteristically
strong diffraction signal of the Se atom in the SeU analog
suggests that anomalous dispersion from Se can be used in
direct RNA structure determination by SAD or MAD
phasing techniques.[9, 13]
The selenophene ring of the base-paired fluorophore
(SeU1406) is projected into the major groove and stacked with
the imidazole ring of G1405 (3.72c, Figure S8). The uracil
ring is stacked with the pyrimidine rings of G1405 (3.70 c)
and C1407 (3.71c). It is well documented that stacking
interaction with neighboring bases and proximity to guanine
residue can reduce the fluorescence efficiency of fluorophores
incorporated into ONs.[20]Hence, the stacked conformation of
SeU in the unbound state of the A-site RNA exhibits lower
fluorescence intensity (Figure 3). However, upon titrating A-
site with aminoglycosides, the nucleoside probe reported the
binding event by enhancement of fluorescence intensity. To
gain further insight on the effect of modification on the A-site
structure and responsiveness of the label, the SeU-A-site
crystal structure was superimposed onto structures of native
A-site RNA and aminoglycosides bound to the native A-site
RNA.
Superimposition of the selenophene-modified and native
decoding site structures reveal that the structures are almost
identical with a RMS distance of 0.367c for 1305 identical
atoms out of 1362 total atoms (Figure 5A). The 2’-OH group
of the G1491 sugar is slightly drawn into the interior of the
decoding site in the A1492-out conformation of the modified
RNA, whereas this is not seen in the structure of the native A-
site model. This 2’-OH group interacts with a bridging water
molecule to A1408 and with a chain of water molecules
beneath the selenophene ring and above a Mg2+ ion (Fig-
ure S9). In addition to thermal melting and CD studies, the
crystal structure confirms that selenophene-modification has
only a minor impact on the native A-site RNA structure.
In the superimposed structures of paromomycin and
neomycin there was no apparent steric clash between the
aminoglycosides and selenophene modification (Figure 5B
and Figure S10).[21, 22] Other than the conserved interactions
between the ligands and decoding site, 6- and 2’’-hydroxyl
groups of aminoglycoside rings II and III, respectively, were
found to be in close proximity with the Se atom (2.2/2.4c and
3.4/2.6c, respectively). These superimposed models indicate
that the SeU modification should not affect binding of
paromomycin and neomycin to the decoding site. This
notion is in consensus with the fluorescence binding experi-
Figure 3. A) Emission spectra (solid lines) of A-site RNA 3·4 as
a function of increasing concentration of paromomycin. The dashed
line represents an emission profile in the absence of aminoglycoside.
B) Curve fitted for the titration of A-site with paromomycin. Normal-
ized fluorescence intensity (FI) at lem=450 nm is plotted against
log[aminoglycoside].
Figure 4. Electron density map around the SeU-modified A-site RNA 3·4
with A1492 flipped out (top) or in (bottom) the RNA helix, as is seen
in a previous A-site model RNA structure.[19a] The selenophene ring is
shown in cyan with the selenium atom shown as an indigo sphere.
The 2Fo@Fc electron density map, contoured at 1.0s, is shown in gray,
and the Fo@Fc electron density map, contoured at 3.0s, is shown in
red (PDB ID: 5T3K).[11] .
Angewandte
ChemieCommunications
2642 www.angewandte.org T 2017 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Angew. Chem. Int. Ed. 2017, 56, 2640 –2644
ments wherein SeU-labeled A-site exhibited binding affinity
comparable to literature reports.[19] In case of tobramycin,
which binds differently to the decoding site as compared to
4,5-disubstituted 2-DOS aminoglycosides,[23] the superim-
posed structure revealed a steric clash between ring III and
the selenophene moiety (Figure 5C). This would explain the
observed lower affinity of tobramycin for the SeU-labeled A-
site. Not surprisingly, mutations of U1406, predicted to confer
antibiotic resistance, are known to reduce the binding of
tobramycin due to a comparable steric clash.[24] For example,
replacing U1406 with adenine residue results in reduction in
affinity of tobramycin (EC50 values, wt: 9.5 mm ; mut:
110 mm).[19a] However, mutation of U1406 does not affect
the binding of 4,5-disubstituted 2-DOS aminoglycosides to A-
site. In this context, SeU-labeledA-site can potentially serve as
a mutant model because the nucleoside probe faithfully
distinguishes the binding of aminoglycosides based on affinity
and 2-DOS class. Such labeled RNA constructs could be used
for screening of small molecule ligands against resistant
bacterial strains.[25]
Further, we compared the conformation of U1406 and its
neighboring bases in the structures of native A-site RNA in
the absence and presence of aminoglycosides and SeU-labeled
A-site to understand the photophysical behavior of SeU in
solution binding experiments. The stacking interaction
between U1406 and G1405 in the unbound state (3.77 c)
and aminoglycoside-bound state (3.72–3.86c) is similar.
However, U1406, which is completely stacked with C1407
(3.89c) in the free A-site structure, is found to be only
partially stacked with C1407 (3.96–4.27c) in all three
aminoglycoside-A-site complexes (Figure S11, Table S2).
Based on these structural observations, it is suggested that
SeU placed at the 1406 position is likely to sense a similar
environment as U1406 upon ligand binding. Hence, enhanced
fluorescence intensity displayed by SeU in ligand binding
experiments can be attributed to a reduced stacking inter-
action between the fluorophore and neighboring bases.
In summary, we have introduced a multipurpose nucleo-
side probe functioning both as an environment-sensitive
fluorophore and an anomalous X-ray diffraction label, which
facilitated the direct correlation of RNA structure and ligand
recognition under equilibrium conditions and in 3D. The new
bifunctional nucleoside probe will be a powerful tool for
combined fluorescence and crystallography studies, including
time-resolved experiments, for example with femtosecond X-
ray laser pulses, on dynamic RNA systems such as ribo-
switches.[26] The responsiveness of the fluorophore to subtle
conformational changes and the strong diffraction signal from
the Se atom as demonstrated by using decoding site RNA
suggest that such a probe, when judiciously placed, would not
only allow the concurrent investigation of RNA structure and
function but also could support integrated approaches to
antibiotics discovery against resistant bacterial strains.
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